Filing Details
- Accession Number:
- 0001179110-14-001745
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-03 20:25:32
- Reporting Period:
- 2014-01-30
- Filing Date:
- 2014-02-03
- Accepted Time:
- 2014-02-03 20:25:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1130598 | Onconova Therapeutics Inc. | ONTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1580074 | Ramesh Kumar | C/O Onconova Therapeutics, Inc. 375 Pheasant Run Newtown PA 18940 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-01-30 | 5,256 | $2.67 | 281,756 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-01-30 | 14,744 | $6.00 | 296,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-01-30 | 20,000 | $15.05 | 276,500 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-01-31 | 20,000 | $6.00 | 296,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-01-31 | 20,000 | $15.03 | 276,500 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-02-03 | 20,000 | $6.00 | 296,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-03 | 20,000 | $15.07 | 276,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2014-01-30 | 5,256 | $0.00 | 5,256 | $2.67 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-01-30 | 14,744 | $0.00 | 14,744 | $6.00 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-01-31 | 20,000 | $0.00 | 20,000 | $6.00 |
Common Stock | Stock Option (right to buy) | Disposition | 2014-02-03 | 20,000 | $0.00 | 20,000 | $6.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2006-01-01 | 2016-01-01 | No | 4 | M | Direct |
90,282 | 2011-04-01 | 2017-04-01 | No | 4 | M | Direct |
70,282 | 2011-04-01 | 2017-04-01 | No | 4 | M | Direct |
50,282 | 2011-04-01 | 2017-04-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.19, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.11, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.30, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- All the transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
- 150,037 shares are held indirectly by the Ramesh Kumar 2012 Trust, of which the reporting person is a trustee.